Pages that link to "Q37503253"

The following pages link to Strategies to overcome host immunity to adenovirus vectors in vaccine development (Q37503253):

Displaying 40 items.

• PEGylated Adenoviruses: From Mice to Monkeys (Q24635276) (← links)
• Crystallographic Structure of Porcine Adenovirus Type 4 Fiber Head and Galectin Domains (Q27663879) (← links)
• Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin (Q28731982) (← links)
• Development of adenoviral vector-based mucosal vaccine against influenza (Q30396642) (← links)
• HIV Antigen Incorporation within Adenovirus Hexon Hypervariable 2 for a Novel HIV Vaccine Approach (Q33646773) (← links)
• Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection (Q34075166) (← links)
• Current progress in the development of a prophylactic vaccine for HIV-1 (Q34502108) (← links)
• Immunogenicity of a recombinant measles-HIV-1 clade B candidate vaccine (Q34505337) (← links)
• Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes (Q35576891) (← links)
• Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity (Q35666180) (← links)
• Structure and Sialyllactose Binding of the Carboxy-Terminal Head Domain of the Fibre from a Siadenovirus, Turkey Adenovirus 3. (Q35791558) (← links)
• Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa (Q36326838) (← links)
• Pharmacological Activation of p53 in Cancer Cells (Q37191174) (← links)
• Epitope Capsid-Incorporation: New Effective Approach for Vaccine Development for Chagas Disease (Q37304346) (← links)
• Crystallization of the head and galectin-like domains of porcine adenovirus isolate NADC-1 fibre. (Q37420351) (← links)
• Hereditary Angioedema as a Metabolic Liver Disorder: Novel Therapeutic Options and Prospects for Cure (Q37452581) (← links)
• Adenovirus: the first effective in vivo gene delivery vector (Q37508260) (← links)
• Immunologic Basis of Vaccine Vectors (Q37804532) (← links)
• Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting (Q37859842) (← links)
• Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives (Q37945171) (← links)
• CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic (Q37974160) (← links)
• Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature. (Q38186768) (← links)
• Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach (Q38364597) (← links)
• Applying genomic and bioinformatic resources to human adenovirus genomes for use in vaccine development and for applications in vector development for gene delivery. (Q38613979) (← links)
• Crystal structure of the fibre head domain of bovine adenovirus 4, a ruminant atadenovirus (Q39004342) (← links)
• Genome Sequence of a Cynomolgus Macaque Adenovirus (CynAdV-1) Isolate from a Primate Colony in the United Kingdom (Q39218445) (← links)
• Preliminary evaluation of safety of conditionally replication adenovirus M4. (Q39220073) (← links)
• Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3). (Q39444094) (← links)
• Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices (Q39756783) (← links)
• Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study (Q40153269) (← links)
• Characterization and functional studies of fowl adenovirus 9 dUTPase (Q40585595) (← links)
• Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate (Q40684243) (← links)
• Crystal structure of raptor adenovirus 1 fibre head and role of the beta-hairpin in siadenovirus fibre head domains. (Q40686770) (← links)
• Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR. (Q41995734) (← links)
• Crystallization of the C-terminal head domain of the fibre protein from a siadenovirus, turkey adenovirus 3. (Q41999660) (← links)
• Oral inoculation of chickens with a candidate fowl adenovirus 9 vector (Q42573299) (← links)
• Envelope protein E1 as vaccine target for western equine encephalitis virus. (Q44155360) (← links)
• Comparative Analysis of Ovine Adenovirus 287 and Human Adenovirus 2 and 5 Based on Their Codon Usage (Q53087410) (← links)
• A novel in vivo inducible expression system in Edwardsiella tarda for potential application in bacterial polyvalence vaccine (Q85028329) (← links)
• A single immunization with spike-functionalized ferritin vaccines elicits neutralizing antibody responses against SARS-CoV-2 in mice (Q99637405) (← links)